日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Cubilin gene mutation screening in Thai Border Collies using double-mismatch allele-specific and multiplex polymerase chain reaction: Implications for Imerslund-Gräsbeck syndrome

利用双错配等位基因特异性和多重聚合酶链式反应对泰国边境牧羊犬进行Cubilin基因突变筛查：对Imerslund-Gräsbeck综合征的启示

期刊:Veterinary World
影响因子:2
doi:10.14202/vetworld.2026.580-590
Lerdkrai, Chommanad; Akrimajirachoote, Nattaphong; Phungphosop, Nuch
PCR
发表日期：2026
文献求助 收藏

Cellular and Molecular Mechanisms of Wound Repair: From Biology to Therapeutic Innovation

伤口修复的细胞和分子机制：从生物学到治疗创新

期刊:Cells
影响因子:5.2
doi:10.3390/cells14231850
Jin, Caijun; Jin, Yongxun; Ding, Zhiyuan; Nuch, Kong Srey; Han, Mira; Shim, JungHee; Chien, Pham Ngoc; Heo, Chan Yeong
细胞生物学
发表日期：2025
文献求助 收藏

Cost-Utility Analysis of Dapagliflozin as an Add-on to Standard of Care for Patients with Chronic Kidney Disease in Thailand

在泰国，达格列净作为慢性肾病患者标准治疗方案的附加疗法的成本效用分析

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-021-02037-6
Vareesangthip, Kriengsak; Deerochanawong, Chaicharn; Thongsuk, Dittaya; Pojchaijongdee, Nuch; Permsuwan, Unchalee
发表日期：2022
文献求助 收藏

Cost-Utility Analysis of Dapagliflozin as an Add-On to Standard Treatment for Patients with Type 2 Diabetes and High Risk of Cardiovascular Disease in Thailand

在泰国，对患有2型糖尿病和心血管疾病高风险的患者，在标准治疗基础上加用达格列净进行成本效益分析

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-021-01088-w
Deerochanawong, Chaicharn; Vareesangthip, Kriengsak; Piyayotai, Dilok; Thongsuk, Dittaya; Pojchaijongdee, Nuch; Permsuwan, Unchalee
糖尿病
心血管疾病
心血管
代谢
发表日期：2021
文献求助 收藏

Prevalence of the MDR1 gene mutation in herding dog breeds and Thai Ridgebacks in Thailand

泰国牧羊犬品种和泰国脊背犬中MDR1基因突变的流行情况

期刊:Veterinary World
影响因子:2
doi:10.14202/vetworld.2021.3015-3020
Lerdkrai, Chommanad; Phungphosop, Nuch
发表日期：2021
文献求助 收藏